Referencies
1. De Oliveira Santos M. Estimativa/2020 – Incidência de Câncer no Brasil. Rev Bras Cancerol . 2020;66(1). doi:10.32635/2176-9745.RBC.2020v66n1.927
2. Santos M de O. Estimativa 2018: Incidência de Câncer no Brasil.Rev Bras Cancerol . 2018;64(1):119-120. doi:10.32635/2176-9745.RBC.2018v64n1.115
3. Wiffen PJ, Derry S, Moore RA, et al. Oral paracetamol (acetaminophen) for cancer pain. Cochrane Pain, Palliative and Supportive Care Group, ed. Cochrane Database Syst Rev . Published online July 12, 2017. doi:10.1002/14651858.CD012637.pub2
4. Portenoy RK, Lesage P. Management of cancer pain. The Lancet . 1999;353(9165):1695-1700. doi:10.1016/S0140-6736(99)01310-0
5. van den Beuken-van Everdingen MHJ, Hochstenbach LMJ, Joosten EAJ, Tjan-Heijnen VCG, Janssen DJA. Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis. J Pain Symptom Manage . 2016;51(6):1070-1090.e9. doi:10.1016/j.jpainsymman.2015.12.340
6. Wiffen PJ, Wee B, Moore RA. Oral morphine for cancer pain. Cochrane Pain, Palliative and Supportive Care Group, ed. Cochrane Database Syst Rev . Published online April 22, 2016. doi:10.1002/14651858.CD003868.pub4
7. Deng D, Fu L, Zhao YX, et al. The Relationship Between Cancer Pain and Quality of Life in Patients Newly Admitted to Wuhan Hospice Center of China. Am J Hosp Palliat Med . 2012;29(1):53-59. doi:10.1177/1049909111418636
8. Dreidi MM, Hamdan-Mansour AM. Pain, Sleep Disturbance, and Quality of Life Among Palestinian Patients Diagnosed with Cancer. J Cancer Educ . 2016;31(4):796-803. doi:10.1007/s13187-015-0946-5
9. Mikan F, Wada M, Yamada M, et al. The Association Between Pain and Quality of Life for Patients With Cancer in an Outpatient Clinic, an Inpatient Oncology Ward, and Inpatient Palliative Care Units. Am J Hosp Palliat Med . 2016;33(8):782-790. doi:10.1177/1049909116630266
10. Marec-Bérard P, Delafosse C, Foussat C. [Cancer-related bone pain in children]. Arch Pediatr Organe Off Soc Francaise Pediatr . 2005;12(2):191-198. doi:10.1016/j.arcped.2004.11.026
11. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain . 1999;82(3):263-274.
12. Widhe B, Widhe T. Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am . 2000;82(5):667-674.
13. Ottaviani G, Jaffe N. The Epidemiology of Osteosarcoma. In: Jaffe N, Bruland OS, Bielack S, eds. Pediatric and Adolescent Osteosarcoma . Vol 152. Springer US; 2009:3-13. doi:10.1007/978-1-4419-0284-9_1
14. Zernikow B, Szybalski K, Hübner-Möhler B, et al. Specialized pediatric palliative care services for children dying from cancer: A repeated cohort study on the developments of symptom management and quality of care over a 10-year period. Palliat Med . 2019;33(3):381-391. doi:10.1177/0269216318818022
15. Madden K, Magno Charone M, Mills S, et al. Systematic Symptom Reporting by Pediatric Palliative Care Patients with Cancer: A Preliminary Report. J Palliat Med . Published online February 13, 2019. doi:10.1089/jpm.2018.0545
16. Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature.Ann Oncol Off J Eur Soc Med Oncol . 2008;19(12):1985-1991. doi:10.1093/annonc/mdn419
17. Cohen MZ, Easley MK, Ellis C, et al. Cancer Pain Management and the JCAHO’s Pain Standards. J Pain Symptom Manage . 2003;25(6):519-527. doi:10.1016/S0885-3924(03)00068-X
18. WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents . World Health Organization; 2018. Accessed March 19, 2019. http://www.ncbi.nlm.nih.gov/books/NBK537492/
19. Maltoni M. Opioids, pain, and fear. Ann Oncol . 2008;19(1):5-7. doi:10.1093/annonc/mdm555
20. Jackson TM, Bittman M, Granowetter L. Pediatric Malignant Bone Tumors: A Review and Update on Current Challenges, and Emerging Drug Targets. Curr Probl Pediatr Adolesc Health Care . 2016;46(7):213-228. doi:10.1016/j.cppeds.2016.04.002
21. Senerchia AA, Macedo CR, Ferman S, et al. Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with high-grade, operable osteosarcomas of the extremities: A report from the Latin American Group of Osteosarcoma Treatment: Metronomic Therapy in Osteosarcoma Patients. Cancer . 2017;123(6):1003-1010. doi:10.1002/cncr.30411
22. On behalf of the Brazilian Collaborative Study Group of Ewing Family of Tumors – EWING1 and the Brazilian Society of Pediatric Oncology – SOBOPE, Becker RG, Gregianin LJ, et al. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group – EWING1. BMC Cancer . 2017;17(1). doi:10.1186/s12885-017-3391-5
23. Eleutério SJP, Senerchia AA, Almeida MT, et al. Osteosarcoma in patients younger than 12 years old without metastases have similar prognosis as adolescent and young adults: Osteosarcoma in Children and AYA. Pediatr Blood Cancer . 2015;62(7):1209-1213. doi:10.1002/pbc.25459
24. Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs . 1988;14(1):9-17.
25. Araujo LC de, Romero B. Pain: evaluation of the fifth vital sign. A theoretical reflection. Rev Dor . 2015;16(4). doi:10.5935/1806-0013.20150060
26. Bieri D, Reeve RA, Champion GD, Addicoat L, Ziegler JB. The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties. Pain . 1990;41(2):139-150.
27. Snaman JM, Baker JN, Ehrentraut JH, Anghelescu DL. Pediatric Oncology: Managing Pain at the End of Life. Pediatr Drugs . 2016;18(3):161-180. doi:10.1007/s40272-016-0168-2
28. Jacob J, Matharu JK, Palat G, et al. End-of-Life Treatments in Pediatric Patients at a Government Tertiary Cancer Center in India.J Palliat Med . 2018;21(7):907-912. doi:10.1089/jpm.2017.0632
29. Chi N-C, Demiris G. Family Caregivers’ Pain Management in End-of-Life Care: A Systematic Review. Am J Hosp Palliat Med . 2017;34(5):470-485. doi:10.1177/1049909116637359
30. Pakos EE, Nearchou AD, Grimer RJ, et al. Prognostic factors and outcomes for osteosarcoma: an international collaboration. Eur J Cancer Oxf Engl 1990 . 2009;45(13):2367-2375. doi:10.1016/j.ejca.2009.03.005
31. Petrilli AS, Brunetto AL, Cypriano MDS, et al. Fifteen Years’ Experience of the Brazilian Osteosarcoma Treatment Group (BOTG): A Contribution from an Emerging Country. J Adolesc Young Adult Oncol . 2013;2(4):145-152. doi:10.1089/jayao.2013.0012
32. Brunetto AL, Castillo LA, Petrilli AS, et al. Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian Collaborative Study Group for Ewing Sarcoma Family Tumors-EWING1: Carboplatin in the Treatment of Ewing Sarcoma. Pediatr Blood Cancer . 2015;62(10):1747-1753. doi:10.1002/pbc.25562
33. Kreyer J, Ranft A, Timmermann B, et al. Impact of the Interdisciplinary Tumor Board of the Cooperative Ewing Sarcoma Study Group on local therapy and overall survival of Ewing sarcoma patients after induction therapy. Pediatr Blood Cancer . 2018;65(12):e27384. doi:10.1002/pbc.27384
34. Spraker-Perlman HL, Barkauskas DA, Krailo MD, et al. Factors influencing survival after recurrence in osteosarcoma: A report from the Children’s Oncology Group. Pediatr Blood Cancer . 2019;66(1):e27444. doi:10.1002/pbc.27444
35. Fernández Urtubia B, Trevigno Bravo A, Rodríguez Zamora N, Palma Torres C, Cid Barria L. Uso de opiáceos en niños con cáncer avanzado en cuidados paliativos. Rev Chil Pediatría . 2016;87(2):96-101. doi:10.1016/j.rchipe.2015.10.006
36. Weltgesundheitsorganisation, ed. WHO Guidelines on the Pharmacological Treatment of Persisting Pain in Children with Medical Illnesses . World Health Organization; 2012.
37. Friedrichsdorf S, Postier A. Management of breakthrough pain in children with cancer. J Pain Res . Published online March 2014:117. doi:10.2147/JPR.S58862
38. Friedrichsdorf SJ. Pain Management in Children with Advanced Cancer and During End-of-life Care. Pediatr Hematol Oncol . 2010;27(4):257-261. doi:10.3109/08880011003663416
39. Anghelescu DL, Tesney JM. Neuropathic Pain in Pediatric Oncology: A Clinical Decision Algorithm. Pediatr Drugs . 2019;21(2):59-70. doi:10.1007/s40272-018-00324-4
40. Petrilli AS, de Camargo B, Filho VO, et al. Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival. J Clin Oncol Off J Am Soc Clin Oncol . 2006;24(7):1161-1168. doi:10.1200/JCO.2005.03.5352
41. Heinemann M, Ranft A, Langer T, et al. Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage? Pediatr Blood Cancer . 2018;65(7):e27011. doi:10.1002/pbc.27011
42. Reed DR, Hayashi M, Wagner L, et al. Treatment pathway of bone sarcoma in children, adolescents, and young adults. Cancer . 2017;123(12):2206-2218. doi:10.1002/cncr.30589
43. Palermo TM, Chambers CT. Parent and family factors in pediatric chronic pain and disability: An integrative approach: Pain . 2005;119(1-3):1-4. doi:10.1016/j.pain.2005.10.027